Vitreous Biomarkers for Alzheimer’s Disease in Patients Undergoing Vitrectomy and Cognitive Function Assessment

Related

• 

  Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial

  Rishi P. Singh, MD

  Annual Meeting Talks

  2018

• 

  Surgical Case Conference

  Carl C. Awh, MD, FASRS

  Carl D. Regillo, MD

  Mohamed AlBahiti, MBBS, FRCSC

  Mohsin H. Ali, MD

  Nishikant J Borse, MS, FMRF, FASRS

  Jonathan S Chang, MD, FASRS

  Albert Li, MD, FASRS

  Zofia Anna Nawrocka (vel Michalewska), MD, PhD

  Manish Nagpal, MD, FRCS (UK) ,FASRS

  Berna Ozkan, MD

  Uriel Rubin, MD

  Jayanth Sridhar, MD

  Victor M Villegas, MD

  Christina Y Weng, MD, MBA, FASRS

  Annual Meeting Talks

  2018

• 

  2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

  Nancy M. Holekamp, MD, FASRS

  Annual Meeting Talks

  2018